Business Standard

Scientists identify cell structure that can help develop new Covid-19 drugs

They said the viruses replicate by transforming host cell membranes into peculiar double-membrane vesicle (DMV) structures

coronavirus, coronavirus vaccine
Premium

In the current study, they noted that the newly made viral genetic material, its RNA molecule, needs to be exported from these DMVs to the cytoplasm to be packaged into complete, infectious forms of the virus.

Press Trust of India Berlin
Scientists have identified a structure in host cells which the novel coronavirus likely uses to synthesise components that will be assembled into fully infectious viruses, an advance which may lead to the development of new drugs against Covid-19.
The study, published in the journal Science Advances, uncovers a coronavirus-specific structure in cells, which may act as a target for much-needed antiviral strategies against this family of viruses.
According to the scientists, including those from the Leibnitz Institute of Experimental Virology in Germany, coronaviruses replicate their large genomes in the host cell's cytosol -- the jelly-like material in which the components of the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in